Literature DB >> 20850388

Neuroimaging changes in mesial temporal lobe epilepsy are magnified in the presence of depression.

Priscila Camile Barioni Salgado1, Clarissa Lin Yasuda, Fernando Cendes.   

Abstract

OBJECTIVE: The aim of this study was to investigate differences in gray matter volume between patients with mesial temporal lobe epilepsy (MTLE) with and without depression using voxel-based morphometry.
METHOD: We included 48 adults with refractory MTLE (31 women, 39.18 ± 8.4 years) and 96 healthy controls (75 women, 37.11 ± 8.9 years). For the psychiatric evaluation, the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Axis I, was used for the diagnosis of depression, and the Beck Depression Inventory, for the determination of symptom intensity. All patients underwent an MRI scan. Patients were separated into two groups: those with MTLE with depression (n = 24) and those with MTLE without depression (n = 24). We performed voxel-based morphometric analysis, comparing patients with controls using the t test.
RESULTS: The number of areas of gray matter volume loss was higher in patients with MTLE with depression than in those with MTLE without depression.
CONCLUSIONS: The evidence of more widespread gray matter volume loss in patients with MTLE and depression calls our attention to the importance of timely recognition and treatment of depression in patients with MTLE and also to the bidirectional relationship between the two disorders and their frequent co-occurrence.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20850388     DOI: 10.1016/j.yebeh.2010.08.012

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  12 in total

Review 1.  Depression in epilepsy: a critical review from a clinical perspective.

Authors:  Christian Hoppe; Christian E Elger
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

2.  Is depression a risk factor of worse response to therapy in epilepsy?

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2011-03       Impact factor: 7.500

Review 3.  Can Neurochemical Changes of Mood Disorders Explain the Increase Risk of Epilepsy or its Worse Seizure Control?

Authors:  Andres M Kanner
Journal:  Neurochem Res       Date:  2017-07-01       Impact factor: 3.996

Review 4.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

Review 5.  Biomarkers of epileptogenesis: psychiatric comorbidities (?).

Authors:  Andres M Kanner; Andrey Mazarati; Matthias Koepp
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 6.  Bidirectional Relations Among Depression, Migraine, and Epilepsy: Do They Have an Impact on Their Response to Treatment?

Authors:  Andres M Kanner
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 7.  Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy.

Authors:  Jamie Maguire; Jay A Salpekar
Journal:  Epilepsy Behav       Date:  2012-11-29       Impact factor: 2.937

Review 8.  Common Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy.

Authors:  Andrey Mazarati; Raman Sankar
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

9.  Mechanisms of Psychiatric Comorbidities in Epilepsy.

Authors:  Jamie Maguire
Journal:  Curr Top Behav Neurosci       Date:  2022

10.  Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations.

Authors:  C S Garcia
Journal:  Epilepsy Res Treat       Date:  2011-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.